14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ARGS
Delisted

Argos Therapeutics Fund Price (Quote)

NASDAQ Stock Exchange
Open Broker Account
$0.0536
+0 (+0%)
At Close: Apr 15, 2020
Forecast Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days $0.0536 $0.0536 Wednesday, 15th Apr 2020 ARGS stock ended at $0.0536. During the day the stock fluctuated 0% from a day low at $0.0536 to a day high of $0.0536.
90 days $0.0536 $0.0536
52 weeks $0.0350 $0.0840

Historical Argos Therapeutics prices

Date Open High Low Close Volume
Aug 05, 2019 $0.0456 $0.0632 $0.0456 $0.0632 247
Aug 02, 2019 $0.0565 $0.0633 $0.0485 $0.0633 976
Aug 01, 2019 $0.0456 $0.0650 $0.0456 $0.0650 15 643
Jul 31, 2019 $0.0456 $0.0635 $0.0456 $0.0635 315
Jul 30, 2019 $0.0635 $0.0635 $0.0635 $0.0635 90
Jul 29, 2019 $0.0456 $0.0635 $0.0456 $0.0635 929
Jul 26, 2019 $0.0553 $0.0635 $0.0553 $0.0635 1 116
Jul 25, 2019 $0.0650 $0.0650 $0.0650 $0.0650 231
Jul 24, 2019 $0.0650 $0.0650 $0.0650 $0.0650 5
Jul 23, 2019 $0.0451 $0.0650 $0.0451 $0.0650 1 778
Jul 22, 2019 $0.0458 $0.0650 $0.0451 $0.0650 3 414
Jul 19, 2019 $0.0461 $0.0650 $0.0461 $0.0650 364
Jul 18, 2019 $0.0460 $0.0613 $0.0460 $0.0613 482
Jul 17, 2019 $0.0650 $0.0650 $0.0650 $0.0650 325
Jul 16, 2019 $0.0460 $0.0650 $0.0460 $0.0650 3 053
Jul 15, 2019 $0.0458 $0.0650 $0.0458 $0.0650 10 521
Jul 12, 2019 $0.0590 $0.0647 $0.0491 $0.0647 21 313
Jul 11, 2019 $0.0461 $0.0461 $0.0461 $0.0461 3 320
Jul 10, 2019 $0.0600 $0.0600 $0.0588 $0.0600 28 412
Jul 09, 2019 $0.0459 $0.0646 $0.0459 $0.0646 449
Jul 08, 2019 $0.0550 $0.0647 $0.0550 $0.0647 921
Jul 05, 2019 $0.0647 $0.0647 $0.0461 $0.0646 54 704
Jul 03, 2019 $0.0481 $0.0601 $0.0481 $0.0601 405
Jul 02, 2019 $0.0580 $0.0648 $0.0481 $0.0648 13 597
Jul 01, 2019 $0.0521 $0.0648 $0.0521 $0.0648 19 324
Click to get the best stock tips daily for free!

About Argos Therapeutics

Argos Therapeutics, Inc. focuses on the development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases in North America. The company develops immunotherapies based on Arcelis, its proprietary technology platform. Its development stage products include AGS-003, which is under Phase III clinical trials for the treatment of metastatic renal cell carcinoma and other cancers; and AGS-004, which ... ARGS Profile

Golden Star

Ticker Date Change Price
LPLA Apr 19 1.64% $262.59
MLI Apr 19 9.87% $52.28
LNG Apr 17 1.33% $156.81
FCN Apr 16 2.58% $207.62
ELV Apr 16 5.12% $506.97
DXC Apr 08 1.39% $20.87
ITCI Apr 05 8.14% $68.44
AKR Apr 05 6.84% $16.53
NSIT Apr 04 0.350% $185.62
VSTS Apr 04 0.638% $18.82
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT